10 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Ergoline derivatives as highly potent and selective antagonists at the somatostatin sst 1 receptor.
Novartis Institutes For Biomedical Research
SAR of the arylpiperazine moiety of obeline somatostatin sst1 receptor antagonists.
Novartis Institutes For Biomedical Research
Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists.
Novartis Institutes For Biomedical Research
Synthesis of DOTA-conjugated multimeric [Tyr3]octreotide peptides via a combination of Cu(I)-catalyzed"click" cycloaddition and thio acid/sulfonyl azide"sulfo-click" amidation and their in vivo evaluation.
Utrecht University
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism.
Crinetics Pharmaceuticals
Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806.
University of Cambridge
The elucidation of somatostatin receptor functions: a current view.
German Institute of Human Nutrition
Differential expression of multiple somatostatin receptors in the rat cerebellum during development.
Dynamique Des Systemes Neuroendocriniens
Identification and characterization of novel somatostatin antagonists.
Cyenamid Agricultural Research Center